Cytokine and growth factor profiling in patients with the metabolic syndrome
暂无分享,去创建一个
Habibollah Esmaily | Majid Ghayour-Mobarhan | Alireza Pasdar | Zahra Meshkat | Seyed Reza Mirhafez | Saied Eslami | Amir Avan | Gordon A Ferns | A. Avan | G. Ferns | M. Ghayour-Mobarhan | S. Mirhafez | A. Pasdar | Z. Meshkat | H. Rahimi | H. Esmaily | Mohsen Mohebati | Hamid Reza Rahimi | Hamed Ghazavi | Mohsen Mohebati | Atefeh Moezzi | Hassan Mehrad-Majd | S. Eslami | A. Moezzi | H. Ghazavi | Hassan Mehrad‐Majd | Hamed Ghazavi
[1] J. Um,et al. Functional Polymorphism of IL-1 Alpha and Its Potential Role in Obesity in Humans and Mice , 2011, PloS one.
[2] Takahisa Kondo,et al. Comparison of Circulating Adiponectin and Proinflammatory Markers Regarding Their Association With Metabolic Syndrome in Japanese Men , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[3] A. Chawla,et al. Connecting type 1 and type 2 diabetes through innate immunity. , 2012, Cold Spring Harbor perspectives in medicine.
[4] A. Jungbauer,et al. Anti-inflammatory properties of culinary herbs and spices that ameliorate the effects of metabolic syndrome. , 2012, Maturitas.
[5] D. Fearon,et al. Inflammation and cardiovascular disease: role of the interleukin-1 receptor antagonist. , 2008, Circulation.
[6] C. Mathieu,et al. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. , 2007, Diabetes research and clinical practice.
[7] H. Minuk,et al. Metabolic syndrome. , 2005, Journal of insurance medicine.
[8] R. Eckel,et al. The metabolic syndrome and inflammation. , 2004, Metabolic syndrome and related disorders.
[9] L Wood,et al. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. , 2001, American journal of physiology. Endocrinology and metabolism.
[10] M. Blagosklonny. TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists , 2013, Cell Death and Disease.
[11] E. Ford. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. , 2003, Atherosclerosis.
[12] L. Groop,et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.
[13] Roisin M Molloy,et al. Automation of biochip array technology for quality results , 2005, Clinical chemistry and laboratory medicine.
[14] S. Baik,et al. Comparison of serum concentrations of C-reactive protein, TNF-alpha, and interleukin 6 between elderly Korean women with normal and impaired glucose tolerance. , 2004, Diabetes research and clinical practice.
[15] K. Thiel,et al. The Epidermal Growth Factor Receptor and Its Ligands in Cardiovascular Disease , 2013, International journal of molecular sciences.
[16] Lijun Yao,et al. Anthocyanin-rich fractions from red raspberries attenuate inflammation in both RAW264.7 macrophages and a mouse model of colitis , 2014, Scientific Reports.
[17] S. Grundy,et al. Clinical Management of Metabolic Syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management , 2004, Arteriosclerosis, Thrombosis and Vascular Biology.
[18] John V Lamont,et al. Development of a high-throughput automated analyzer using biochip array technology. , 2005, Clinical chemistry.
[19] Y. Miyazaki,et al. Tumor necrosis factor α and insulin resistance in obese type 2 diabetic patients , 2003, International Journal of Obesity.
[20] Haiyuan Yu,et al. Detecting overlapping protein complexes in protein-protein interaction networks , 2012, Nature Methods.
[21] J. Fernández-Real,et al. Insulin resistance and chronic cardiovascular inflammatory syndrome. , 2003, Endocrine reviews.
[22] Faloia Emanuela,et al. Inflammation as a Link between Obesity and Metabolic Syndrome , 2012, Journal of nutrition and metabolism.
[23] P. Scherer,et al. Adipose tissue, inflammation, and cardiovascular disease. , 2005, Circulation research.
[24] A. Shen,et al. Interferon gamma (IFN-γ) disrupts energy expenditure and metabolic homeostasis by suppressing SIRT1 transcription , 2011, Nucleic acids research.
[25] S. Grundy,et al. Clinical Management of Metabolic Syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management , 2004, Circulation.
[26] A. D. de Craen,et al. Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes : the Leiden 85-Plus Study. , 2002, Diabetes.
[27] R. Gaynor,et al. Identification of NF-κB-regulated genes induced by TNFα utilizing expression profiling and RNA interference , 2004, Oncogene.
[28] M. Margaglione,et al. Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. , 2004, Metabolism: clinical and experimental.
[29] V. Mehra,et al. Cytokines and cardiovascular disease , 2005, Journal of leukocyte biology.
[30] H. Brenner,et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. , 2000, Diabetes care.
[31] Esko Vanninen,et al. Multiple Abnormalities in Glucose and Energy Metabolism and Coordinated Changes in Levels of Adiponectin, Cytokines, and Adhesion Molecules in Subjects With Metabolic Syndrome , 2004, Circulation.
[32] S. Yaturu,et al. Relationship of elevated osteoprotegerin with insulin resistance, CRP, and TNF-alpha levels in men with type 2 diabetes. , 2008, Cytokine.
[33] A. Bonnefond,et al. Associations of vascular endothelial growth factor (VEGF) with adhesion and inflammation molecules in a healthy population. , 2013, Cytokine.
[34] A. Gotto,et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). , 2004, The American journal of cardiology.
[35] M. Ghayour-Mobarhan,et al. Dietary intake of patients with angiographically defined coronary artery disease and that of healthy controls in Iran , 2014, European Journal of Clinical Nutrition.
[36] Y. Miyazaki,et al. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients. , 2003, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[37] Nancy R Cook,et al. C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women , 2003, Circulation.
[38] R. Gaynor,et al. Identification of NF-κB-regulated genes induced by TNFα utilizing expression profiling and RNA interference , 2003, Oncogene.
[39] G. Shi,et al. Mast cells and metabolic syndrome. , 2012, Biochimica et biophysica acta.
[40] J. Gussekloo,et al. The Leiden 85-plus Study , 2000 .
[41] M. Mirarefin,et al. Association of metabolic syndrome with inflammatory mediators in women with previous gestational diabetes mellitus , 2013, Journal of Diabetes & Metabolic Disorders.
[42] Nathan D. Wong,et al. Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults , 2004, Circulation.
[43] D. Song,et al. Serum tumor necrosis factor-alpha levels and components of the metabolic syndrome in obese adolescents. , 2004, Metabolism: clinical and experimental.
[44] G. Hotamisligil,et al. Nutrient sensing and inflammation in metabolic diseases , 2008, Nature Reviews Immunology.
[45] A. Avan,et al. An imbalance in serum concentrations of inflammatory and anti-inflammatory cytokines in hypertension. , 2014, Journal of the American Society of Hypertension : JASH.
[46] I. S. Wood,et al. Adipokines: inflammation and the pleiotropic role of white adipose tissue , 2004, British Journal of Nutrition.
[47] Fernando Costa,et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. , 2006, Current opinion in cardiology.
[48] Jukka T Salonen,et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.